Evidence map›Paper›PMID 24553734›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

Delayed noradrenergic activation in the dorsal hippocampus promotes the long-term persistence of extinguished fear.

Ning Chai, Jian-Feng Liu, Yan-Xue Xue, Chang Yang, Wei Yan, Hui-Min Wang, Yi-Xiao Luo, Hai-Shui Shi, Ji-Shi Wang, Yan-Ping Bao and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

  1. Fear extinction induces maladaptive generalization via noradrenergic and GABAergic systems.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Anxiety and hippocampal neuronal activity: Relationship and potential mechanisms.Cognitive, affective & behavioral neuroscience · 2022
    Review
  4. Article
  5. Article
  6. Serotonin 5-HTInternational journal of molecular sciences · 2019
    Article
  7. Review
  8. Article
  9. Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  10. Noradrenergic Modulation of Fear Conditioning and Extinction.Frontiers in behavioral neuroscience · 2018
    Review
  11. Calpain-GRIP Signaling in Nucleus Accumbens Core Mediates the Reconsolidation of Drug Reward Memory.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  12. Article
  13. Article
  14. Role of TAAR1 within the Subregions of the Mesocorticolimbic Dopaminergic System in Cocaine-Seeking Behavior.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  15. EphB2 in the Medial Prefrontal Cortex Regulates Vulnerability to Stress.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  16. AMPK Signaling in the Dorsal Hippocampus Negatively Regulates Contextual Fear Memory Formation.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  17. Article
  18. Article
  19. Role of hippocampal β-adrenergic and glucocorticoid receptors in the novelty-induced enhancement of fear extinction.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Ning Chai1] Peking University Sixth Hospital/Institute of Mental Health and Key Laboratory of Mental Health, Ministry of Health, Beijing, China [2] Institute of Mental Health and Hebei Brain Ageing and Cognitive Neuroscience Laboratory, Hebei Medical University, Shijiazhuang, China.
Jian-Feng Liu1] Peking University Sixth Hospital/Institute of Mental Health and Key Laboratory of Mental Health, Ministry of Health, Beijing, China [2] National Institute on Drug Dependence, Peking University, Beijing, China.
Yan-Xue XueNational Institute on Drug Dependence, Peking University, Beijing, China.
Chang YangAffiliated Hospital and School of Pharmacy of Guiyang Medical University, Guiyang, China.
Wei Yan1] Peking University Sixth Hospital/Institute of Mental Health and Key Laboratory of Mental Health, Ministry of Health, Beijing, China [2] National Institute on Drug Dependence, Peking University, Beijing, China.
Hui-Min Wang1] Peking University Sixth Hospital/Institute of Mental Health and Key Laboratory of Mental Health, Ministry of Health, Beijing, China [2] National Institute on Drug Dependence, Peking University, Beijing, China.
Yi-Xiao Luo1] Peking University Sixth Hospital/Institute of Mental Health and Key Laboratory of Mental Health, Ministry of Health, Beijing, China [2] National Institute on Drug Dependence, Peking University, Beijing, China.
Hai-Shui ShiDepartment of Biochemistry and Molecular Biology, Basic Medical College, Hebei Medical University, Shijiazhuang, China.
Ji-Shi WangAffiliated Hospital and School of Pharmacy of Guiyang Medical University, Guiyang, China.
Yan-Ping BaoNational Institute on Drug Dependence, Peking University, Beijing, China.
Shi-Qiu Meng1] Peking University Sixth Hospital/Institute of Mental Health and Key Laboratory of Mental Health, Ministry of Health, Beijing, China [2] National Institute on Drug Dependence, Peking University, Beijing, China.
Zeng-Bo DingNational Institute on Drug Dependence, Peking University, Beijing, China.
Xue-Yi WangInstitute of Mental Health and Hebei Brain Ageing and Cognitive Neuroscience Laboratory, Hebei Medical University, Shijiazhuang, China.
Lin Lu1] Peking University Sixth Hospital/Institute of Mental Health and Key Laboratory of Mental Health, Ministry of Health, Beijing, China [2] National Institute on Drug Dependence, Peking University, Beijing, China [3] Peking-Tsinghua Center for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.
Peking University · CNGuiyang Medical University · CNHebei Medical University · CNNational Institutes for Food and Drug Control · CNPeking University Sixth Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fear extinction has been extensively studied, but little is known about the molecular processes that underlie the persistence of extinction long-term memory (LTM). We found that microinfusion of norepinephrine (NE) into the CA1 area of the dorsal hippocampus during the early phase (0 h) after extinction enhanced extinction LTM at 2 and 14 days after extinction. Intra-CA1 infusion of NE during the late phase (12 h) after extinction selectively promoted extinction LTM at 14 days after extinction that was blocked by the β-receptor antagonist propranolol, protein kinase A (PKA) inhibitor Rp-cAMPS, and protein synthesis inhibitors anisomycin and emetine. The phosphorylation levels of PKA, cyclic adenosine monophosphate response element-binding protein (CREB), GluR1, and the membrane GluR1 level were increased by NE during the late phase after extinction that was also blocked by propranolol and Rp-cAMPS. These results suggest that the enhancement of extinction LTM persistence induced by NE requires the activation of the β-receptor/PKA/CREB signaling pathway and membrane GluR1 trafficking. Moreover, extinction increased the phosphorylation levels of Erk1/2, CREB, and GluR1, and the membrane GluR1 level during the late phase, and anisomycin/emetine alone disrupted the persistence of extinction LTM, indicating that the persistence of extinction LTM requires late-phase protein synthesis in the CA1. Propranolol and Rp-cAMPS did not completely disrupt the persistence of extinction LTM, suggesting that another β-receptor/PKA-independent mechanism underlies the persistence of extinction LTM. Altogether, our results showed that enhancing hippocampal noradrenergic activity during the late phase after extinction selectively promotes the persistence of extinction LTM.

Indexed as

AnimalsCA1 Region, HippocampalConditioning, PsychologicalExtinction, PsychologicalFearMaleMemory, Long-TermMotor ActivityNorepinephrinePhosphorylationProtein BiosynthesisRatsRats, Sprague-DawleyReceptors, Adrenergic, betaSignal TransductionNorepinephrineReceptors, Adrenergic, beta

Identifiers

PMID24553734
PMCPMC4059903
OpenAlexW2045735318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.